Published in Ear Nose Throat J on April 01, 2005
Oral vs intratympanic corticosteroid therapy for idiopathic sudden sensorineural hearing loss: a randomized trial. JAMA (2011) 2.52
Facial nerve grading instruments: systematic review of the literature and suggestion for uniformity. Plast Reconstr Surg (2015) 2.10
Hyperbaric compression in the guinea pig with perilymph fistula. Otolaryngol Head Neck Surg (2003) 2.01
Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Otolaryngol Head Neck Surg (2004) 1.99
Sensorineural hearing loss associated with neomycin eardrops and nonintact tympanic membranes. Otolaryngol Head Neck Surg (2012) 1.98
Ototoxicity after radiotherapy for head and neck tumors. Int J Radiat Oncol Biol Phys (2007) 1.62
Management of anomalies of the third and fourth branchial pouches. Int J Pediatr Otorhinolaryngol (2004) 1.53
Novel rat model of tympanostomy tube otorrhea. Int J Pediatr Otorhinolaryngol (2011) 1.38
Three-dimensional volumetrics for tracking vestibular schwannoma growth in neurofibromatosis type II. Neurosurgery (2008) 1.30
Impact of engineered surface microtopography on biofilm formation of Staphylococcus aureus. Biointerphases (2007) 1.28
Postoperative infection in cochlear implant patients. Otolaryngol Head Neck Surg (2004) 1.14
Petrous anatomy for middle fossa approach. Laryngoscope (2003) 1.13
Suggested response criteria for phase II antitumor drug studies for neurofibromatosis type 2 related vestibular schwannoma. J Neurooncol (2009) 1.10
Prostaglandin E2 inhibition of keloid fibroblast migration, contraction, and transforming growth factor (TGF)-beta1-induced collagen synthesis. Wound Repair Regen (2007) 1.08
Repair of the tympanic membrane with urinary bladder matrix. Laryngoscope (2009) 1.01
Cellular telephone use and risk of intratemporal facial nerve tumor. Laryngoscope (2003) 0.99
Subglottic stenosis examined as a fibrotic response to airway injury characterized by altered mucosal fibroblast activity. Arch Otolaryngol Head Neck Surg (2010) 0.99
Prostaglandin E2 differentially modulates human fetal and adult dermal fibroblast migration and contraction: implication for wound healing. Wound Repair Regen (2006) 0.99
Comparison of performance by otolaryngologists, pediatricians, and general practioners on an otoendoscopic diagnostic video examination. Int J Pediatr Otorhinolaryngol (2004) 0.98
Otologics Middle Ear Transducer Ossicular Stimulator: performance results with varying degrees of sensorineural hearing loss. Acta Otolaryngol (2004) 0.97
Prostaglandin E2 is activated by airway injury and regulates fibroblast cytoskeletal dynamics. Laryngoscope (2009) 0.96
Fetal dermal fibroblasts retain a hyperactive migratory and contractile phenotype under 2-and 3-dimensional constraints compared to normal adult fibroblasts. Tissue Eng (2007) 0.96
Evolution in the management of facial nerve schwannoma. Laryngoscope (2011) 0.94
External auditory canal stenosis after radiation therapy. Laryngoscope (2002) 0.94
Autologous fat grafting for the refractory patulous eustachian tube. Otolaryngol Head Neck Surg (2003) 0.93
Elucidating the role of interleukin 1beta and prostaglandin E2 in upper airway mucosal wound healing. Arch Otolaryngol Head Neck Surg (2007) 0.92
Long-term hearing preservation after middle fossa removal of vestibular schwannoma. Otolaryngol Head Neck Surg (2003) 0.92
Acute and chronic changes in the subglottis induced by graded carbon dioxide laser injury in the rabbit airway. Arch Otolaryngol Head Neck Surg (2008) 0.90
Concordance of bilateral vestibular schwannoma growth and hearing changes in neurofibromatosis 2: neurofibromatosis 2 natural history consortium. Otol Neurotol (2009) 0.90
Differential regulation of free-floating collagen gel contraction by human fetal and adult dermal fibroblasts in response to prostaglandin E2 mediated by an EP2/cAMP-dependent mechanism. Wound Repair Regen (2007) 0.89
Radiosurgery for paraganglioma of the temporal bone. Head Neck (2002) 0.88
Graded carbon dioxide laser-induced subglottic injury in the rabbit model. Arch Otolaryngol Head Neck Surg (2007) 0.88
Biofilm formation in an in vitro model of cochlear implants with removable magnets. Otolaryngol Head Neck Surg (2007) 0.88
Outcome of treatment of respiratory tract infections due to Streptococcus pneumoniae, including drug-resistant strains, with pharmacokinetically enhanced amoxycillin/clavulanate. Int J Antimicrob Agents (2002) 0.88
Lipochoristomas (lipomatous tumors) of the acoustic nerve. Arch Pathol Lab Med (2003) 0.87
Hearing preservation with the middle cranial fossa approach for neurofibromatosis type 2. Otol Neurotol (2011) 0.87
Hearing changes after diagnosis in neurofibromatosis type 2. Otol Neurotol (2004) 0.86
Single vertical incision for Baha implant surgery: preliminary results. Otolaryngol Head Neck Surg (2009) 0.86
Digital music exposure reliably induces temporary threshold shift in normal-hearing human subjects. Ear Hear (2012) 0.86
Distribution of nonvestibular cranial nerve schwannomas in neurofibromatosis 2. Otol Neurotol (2007) 0.86
Age-dependent differential expression of fibronectin variants in skin and airway mucosal wounds. Arch Otolaryngol Head Neck Surg (2007) 0.85
Cochlear implant magnet displacement with minor head trauma. Otolaryngol Head Neck Surg (2005) 0.85
Management of group A beta-hemolytic streptococcal pharyngotonsillitis in children. J Fam Pract (2006) 0.85
Prostaglandin E2 differentially regulates contraction and structural reorganization of anchored collagen gels by human adult and fetal dermal fibroblasts. Wound Repair Regen (2009) 0.84
Biofilm formation by Pseudomonas aeruginosa on ossicular reconstruction prostheses. Am J Otolaryngol (2009) 0.84
A log-normal distribution model of the effect of bacteria and ear fenestration on hearing loss: a Bayesian approach. Stat Med (2004) 0.84
Dexamethasone does not alter in vitro antibacterial efficacy of gentamicin. Otolaryngol Head Neck Surg (2007) 0.84
Management of nontuberculous mycobacterial cervical lymphadenitis. Arch Otolaryngol Head Neck Surg (2003) 0.84
Mucosal wound healing in a rabbit model of subglottic stenosis: biochemical analysis of secretions. Arch Otolaryngol Head Neck Surg (2005) 0.83
Tympanic membrane metalloproteinase inflammatory response. Otolaryngol Head Neck Surg (2003) 0.82
A paradigm shift in salvage surgery for radiated vestibular schwannoma. Otol Neurotol (2011) 0.82
The effect of famciclovir on delayed facial paralysis after acoustic tumor resection. Laryngoscope (2008) 0.82
Development of a calcium alginate tympanostomy tube. Laryngoscope (2010) 0.81
Short treatment durations for acute bacterial rhinosinusitis: Five days of gemifloxacin versus 7 days of gemifloxacin. Otolaryngol Head Neck Surg (2002) 0.81
Skull base fungal osteomyelitis in an immunocompetent host. Otolaryngol Head Neck Surg (2002) 0.81
Preoperative computed tomography may fail to detect patients at risk for perilymph gusher. Ear Nose Throat J (2005) 0.81
Effect of blood and mucus on tympanostomy tube biofilm formation. Laryngoscope (2008) 0.81
Neurofibromatosis 2. Otolaryngol Clin North Am (2012) 0.81
Cochlear nerve diameter in normal hearing ears using high-resolution magnetic resonance imaging. Laryngoscope (2009) 0.80
Management of acoustic schwannoma. Am J Otolaryngol (2004) 0.80
Otologic and audiologic outcomes with the Furlow and von Langenbeck with intravelar veloplasty palatoplasties in unilateral cleft lip and palate. Cleft Palate Craniofac J (2010) 0.80
Opening plugged tympanostomy tubes: effect of biofilm formation. Otolaryngol Head Neck Surg (2006) 0.80
Efficacy of disinfecting solutions in removing biofilms from polyvinyl chloride tracheostomy tubes. Laryngoscope (2012) 0.80
Prevention and treatment of cerebrospinal fluid leak after translabyrinthine acoustic tumor removal. Otol Neurotol (2007) 0.80
Matrix metalloproteinases in a gerbil cholesteatoma model. Otolaryngol Head Neck Surg (2003) 0.79
Prevention of gentamicin-induced apoptosis with the mitochondria-targeted antioxidant mitoquinone. Laryngoscope (2012) 0.79
The evolution of surgical approaches for posterior fossa meningiomas. Otol Neurotol (2004) 0.79
Impact of transplanted fibroblasts on rabbit skin wounds. Arch Otolaryngol Head Neck Surg (2003) 0.79
Geniculate ganglion hemangiomas: clinical results and long-term follow-up. Otol Neurotol (2010) 0.79
Survey of methods of facial palsy documentation in use by members of the Sir Charles Bell Society. Laryngoscope (2014) 0.79
Effectiveness of pediatric tracheostomy tube cleaning. Arch Otolaryngol Head Neck Surg (2012) 0.78
Audiology in the sudden hearing loss clinical trial. Otol Neurotol (2012) 0.78
Adult-fetal fibroblast interactions: effects on cell migration and implications for cell transplantation. Cell Transplant (2005) 0.78
Fibroblast transplantation in the airway: implications for subglottic stenosis. Arch Otolaryngol Head Neck Surg (2005) 0.78
Surgical management of skull base chondroblastoma. Laryngoscope (2007) 0.78
Mitochondria-targeted antioxidant MitoQ reduces gentamicin-induced ototoxicity. Otol Neurotol (2014) 0.78
Cerebrospinal fluid leak of the fallopian canal. Ear Nose Throat J (2013) 0.78
Aural irrigation using the OtoClear Safe Irrigation System in children. Int J Pediatr Otorhinolaryngol (2004) 0.78
Longitudinal study of growth of children with unilateral cleft-lip palate from birth to two years of age. Cleft Palate Craniofac J (2009) 0.78
Amplitude modulated S-tones can be superior to noise for tinnitus reduction. Am J Audiol (2014) 0.78
Stereotactic radiosurgery for facial nerve schwannomas: meta-analysis and clinical review. Otol Neurotol (2015) 0.78
Effects of ciprofloxacin-dexamethasone on myringotomy wound healing. Laryngoscope (2007) 0.78
Mitigation of hearing loss from semi-circular canal transection in pseudomonas otitis media with ciprofloxacin-dexamethasone irrigation. Otol Neurotol (2006) 0.77
Effect of ossicular prosthesis biofilms on middle ear scarring and hearing outcomes. Otol Neurotol (2009) 0.77
Evaluation of apoptotic markers in HEI-OC1 cells treated with gentamicin with and without the mitochondria-targeted antioxidant mitoquinone. Otol Neurotol (2015) 0.77
Topical ciprofloxacin/dexamethasone otic suspension is superior to ofloxacin otic solution in the treatment of granulation tissue in children with acute otitis media with otorrhea through tympanostomy tubes. Otolaryngol Head Neck Surg (2004) 0.77
Computerized physician-order entry: are we there yet? Otolaryngol Clin North Am (2002) 0.77
Community-acquired methicillin-resistant Staphylococcus aureus in children and adolescents: changing trends. Arch Otolaryngol Head Neck Surg (2003) 0.77
Errors in the diagnosis and management of necrotizing otitis externa. Otolaryngol Head Neck Surg (2010) 0.77
Pharmacokinetically enhanced amoxicillin/clavulanate (2,000/125 mg) in acute bacterial rhinosinusitis caused by Streptococcus pneumoniae, including penicillin-resistant strains. Ear Nose Throat J (2006) 0.76
Clinical and histopathologic features of recurrent vestibular schwannoma (acoustic neuroma) after stereotactic radiosurgery. Otol Neurotol (2003) 0.76
Hearing loss with semicircular canal transection and Pseudomonas aeruginosa otitis media. Otolaryngol Head Neck Surg (2004) 0.76
Biofilm formation on coated silicone tympanostomy tubes. Int J Pediatr Otorhinolaryngol (2012) 0.76
Biofilm formation in cochlear implants with cochlear drug delivery channels in an in vitro model. Otolaryngol Head Neck Surg (2007) 0.76
AM-111 prevents hearing loss from semicircular canal injury in otitis media. Laryngoscope (2010) 0.76
Identification of a pre-mRNA splicing factor, arginine/serine-rich 3 (Sfrs3), and its co-expression with fibronectin in fetal and postnatal rabbit airway mucosal and skin wounds. Biochim Biophys Acta (2005) 0.76
Community-based treatment of acute uncomplicated bacterial rhinosinusitis with gatifloxacin. Otolaryngol Head Neck Surg (2002) 0.76
Endolymphatic hydrops perspectives 2012. Curr Opin Otolaryngol Head Neck Surg (2012) 0.76